Medtronic releases all-in-one device in Europe:
This article was originally published in Clinica
Medtronic has announced the European commercial release of its device for fast and slow heart rhythms. The Medtronic Jewel AF is an implantable arrhythmia management device that has both detection and therapeutic capabilities. Medtronic claims that the Jewel AF is the world's first device to deliver tiered atrial therapies and pacing. It will first be indicated for patients who suffer fast ventricular arrhythmias. The device is still under clinical evaluation in the US.
You may also be interested in...
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.